ClinicalTrials.gg
Active, not recruitingNCT07576088Updated May 8, 2026

Multimodal Physiotherapy for Balance and Vertigo in BPPV Patients

An interventional study of Multimodal Physiotherapy and Epley Maneuver in Benign Paroxysmal Positional Vertigo, Vertigo and Balance Disorder, sponsored by Riphah International University. Active, not recruiting at 1 site in Pakistan. Open to participants aged 22 Years to 79 Years. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as active, not recruiting.
  • Registered 10 months after the study started (first participant enrolled Jun 2025, registered May 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
22 Years to 79 Years
Sex
All
01

Study summary

This study aims to evaluate the effects of a multimodal physiotherapy approach on balance, vertigo, fear of falling, and quality of life in patients with benign paroxysmal positional vertigo (BPPV). BPPV is a common vestibular disorder that causes dizziness and balance problems, leading to an increased risk of falls and reduced quality of life. In this randomized controlled trial, participants will be assigned to two groups: one receiving a multimodal physiotherapy program including patient education, Epley maneuver, and balance training, and the other receiving standard Epley maneuver treatment. The intervention will be conducted over four weeks. Outcomes will be assessed using standardized tools for balance, vertigo, fear of falling, and quality of life. The study aims to determine whether a combined physiotherapy approach provides better outcomes than standard treatment alone.

Read the detailed description

Benign paroxysmal positional vertigo (BPPV) is one of the most common vestibular disorders, characterized by brief episodes of vertigo triggered by changes in head position. It significantly affects balance, mobility, and quality of life, and increases the risk of falls, especially in older adults. Although repositioning maneuvers such as the Epley maneuver are considered the standard treatment, many patients continue to experience residual dizziness, imbalance, and fear of falling.

A multimodal physiotherapy approach that combines patient education, vestibular rehabilitation, and balance training may provide a more comprehensive strategy to address these residual impairments. This approach targets both the vestibular and functional components of recovery, potentially improving overall patient outcomes.

This study is a single-blinded randomized controlled trial designed to evaluate the effects of a multimodal physiotherapy approach compared to standard treatment in patients with BPPV. Participants aged 22 to 79 years diagnosed with BPPV will be recruited using a non-probability convenience sampling technique. Participants will be randomly allocated into two groups: the intervention group receiving patient education, Epley maneuver, and balance training, and the control group receiving only the Epley maneuver. The intervention will be administered three times per week for four weeks.

Outcome measures will include the Dynamic Gait Index for balance, Dizziness Handicap Inventory for vertigo, Falls Efficacy Scale-International for fear of falling, and SF-36 for quality of life. Assessments will be conducted at baseline and after completion of the intervention.

The results of this study will provide evidence on whether a multimodal physiotherapy approach is more effective than standard treatment in improving balance, reducing vertigo symptoms, decreasing fear of falling, and enhancing quality of life in patients with BPPV.

02

Conditions studied

  • Benign Paroxysmal Positional Vertigo
  • Vertigo
  • Balance Disorder

Keywords

  • Benign Paroxysmal Positional Vertigo
  • Balance
  • Fear of fall
  • Multimodal Physiotherapy Approach
  • Quality of Life
  • Vertigo
03

In context

Benign Paroxysmal Positional Vertigo

75 studies on the registry are indexed under Benign Paroxysmal Positional Vertigo; 15 are open to participants now.

This study's planned enrollment of 46 is below the median of 78 across 62 interventional studies indexed under Benign Paroxysmal Positional Vertigo.

Browse Benign Paroxysmal Positional Vertigo studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age group between (22-79). Both the genders Male and Female were included. Diagnosed with posterior canal benign paroxysmal positional vertigo (PC-BPPV) confirmed by a positive Dix-Hall pike maneuver.

Onset of symptoms within the past 3 months. Dynamic Balance impairment by DGI > 21. All patients had history of at least two or more attacks of BPPV over 6 months.

Exclusion criteria

Exclusion Criteria:

Patients with a history of cervical spine injuries. Patients taking anti-vertigo medication. Patients with a previous diagnosis of Meniere's disease, migraine, or vestibular neuritis Patients with a previous history of neurological diseases. Cases with bilateral involvement. Absence of systemic diseases without medical control and absence of functional limitations that impede independent walking.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Multimodal Physiotherapy

    participants will receive a multimodal physiotherapy program including patient education, Epley maneuver, and balance training, administered three times per week for four weeks.

    Behavioral: Multimodal Physiotherapy · Procedure: Epley Maneuver

  • Active comparator
    epley Maneuver

    Participants will receive standard treatment using the Epley maneuver, administered three times per week for four weeks.

    Procedure: Epley Maneuver

Interventions

  • BehavioralMultimodal Physiotherapy

    A combined rehabilitation approach including vestibular rehabilitation, patient education, and balance training aimed at improving balance, reducing vertigo, decreasing fear of falling, and enhancing quality of life.

    Also known as: Multimodal Physiotherapy Approach (MPA)

  • ProcedureEpley Maneuver

    A repositioning technique involving sequential head and body movements to relocate displaced otoconia within the semicircular canals to relieve symptoms of benign paroxysmal positional vertigo.

06

What researchers measure

Primary outcomes

  1. Balance

    Balance will be assessed using the Dynamic Gait Index (DGI), a validated tool that evaluates gait, stability, and functional mobility in individuals with balance disorders.

    Time frame: Baseline and Week 4

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — There is no plan to share individual participant data. All data will be kept confidential and used solely for academic and research purposes.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07576088
Responsible party
Sponsor
First posted
May 8, 2026
Start date
Jun 5, 2025
Primary completion
Jul 6, 2026 (estimated)
Completion
Aug 6, 2026 (estimated)
Last update
May 8, 2026

Study contacts

wajeeha zia, PhD
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion